about
Established in 1968, Lupin is a global pharmaceutical company focused on developing and distributing a diverse range of healthcare products. Its portfolio includes generics, branded generics, complex generics, APIs, biosimilars, and specialty medicin...
Read More
1963.50
17.70
(0.91%)
1.0M
NSE+BSE Volume
NSE 31 Oct, 2025 3:31 PM (IST)
Board Meeting
The next board meeting for Lupin Ltd. is on 06 Nov 2025 for the purpose of Quarterly Results & Others
See details